ATAD2 is overexpressed in gastric cancer and serves as an independent poor prognostic biomarker
- 359 Downloads
ATPase family, AAA domain containing 2 (ATAD2) has been found overexpressed in various cancer types and correlated with malignant status and poor prognosis. However, little is known about the clinical significance of ATAD2 in gastric cancer patients. The aim of this study was to explore the clinical and prognostic significance of ATAD2 in gastric cancer.
The mRNA and protein levels expression of ATAD2 were detected in clinical tissue samples by qRT-PCR and immunohistochemistry, respectively. We examined the ATAD2 protein expression by immunohistochemistry. Furthermore, we analyzed the association between ATAD2 expression and clinicopathological features including prognosis in 166 gastric cancer samples.
In our results, ATAD2 mRNA and protein were highly expressed in gastric cancer samples. ATAD2 overexpression was correlated with advanced clinical stage, tumor depth, lymph node metastasis, and distant metastasis. According to the survival analysis, ATAD2 protein overexpression was a poor independent prognostic factor for gastric cancer patients.
In summary, ATAD2 could serve as a prognostic biomarker for gastric cancer patients.
KeywordsATAD2 Gastric cancer Prognosis Biomarker
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interests.
All procedures performed in studies involving human participants were in accordance with Research Ethics Committee of Shandong Provincial Qianfoshan Hospital and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
- 14.Kalashnikova EV, Revenko AS, Gemo AT, Andrews NP, Tepper CG, Zou JX, et al. ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2. Cancer Res. 2010;70(22):9402–12. doi: 10.1158/0008-5472.CAN-10-1199.CrossRefPubMedPubMedCentralGoogle Scholar
- 22.Raeder MB, Birkeland E, Trovik J, Krakstad C, Shehata S, Schumacher S, et al. Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers. PLoS ONE. 2013;8(2):e54873. doi: 10.1371/journal.pone.0054873.CrossRefPubMedPubMedCentralGoogle Scholar